Description of key strategic decisions facing the scientific founder and CEO of promising early stage bio-pharmaceutical company company.l should establish the proposed alliance with the pharmaceutical company? Whether it should create a nutraceuticals business in parallel to its efforts to develop an anti-aging treatment? And if he is licensed second candidate for drug development? “Hide
by Toby Stuart, David Kiron Source: Harvard Business School 24 pages. Publication Date: March 20, 2008. Prod. #: 808112-PDF-ENG
How We Work?
Just email us your case materials and instructions to email@example.com and confirm your order by making the payment here
Other Similar Case Solutions like